Calidi BiotherapeuticsNYSE American: CLDI

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

01 November 2021

Next earnings report:

30 August 2024

Last dividends:

N/A

Next dividends:

N/A
$12.84 M
-95%vs. 3y high
19%vs. sector
-vs. 3y high
-vs. sector
-79%vs. 3y high
11%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Fri, 28 Jun 2024 23:54:09 GMT
$0.20-$0.01(-4.76%)

Dividend

No data over the past 3 years

Analysts recommendations

Institutional Ownership

CLDI Latest News

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
businesswire.com31 May 2024 Sentiment: NEUTRAL

SAN DIEGO--(BUSINESS WIRE)---- $CLDI #immunotherapy--Calidi Biotherapeutics Announces Exercise of Warrants for $1.9 Million Gross Proceeds.

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
accesswire.com17 May 2024 Sentiment: NEUTRAL

RedChip Companies is set to broadcast interviews with Calidi Biotherapeutics Inc. (NYSE American:CLDI) and Unusual Machines Inc. (NYSE American:UMAC) on the RedChip Small Stocks, Big Money™ show on Bloomberg TV this Saturday, May 18, at 7 p.m. ET.

What type of business is Calidi Biotherapeutics?

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is based in San Diego, California.

What sector is Calidi Biotherapeutics in?

Calidi Biotherapeutics is in the Healthcare sector

What industry is Calidi Biotherapeutics in?

Calidi Biotherapeutics is in the Biotechnology industry

What country is Calidi Biotherapeutics from?

Calidi Biotherapeutics is headquartered in United States

When did Calidi Biotherapeutics go public?

Calidi Biotherapeutics initial public offering (IPO) was on 01 November 2021

What is Calidi Biotherapeutics website?

https://calidibio.com

Is Calidi Biotherapeutics in the S&P 500?

No, Calidi Biotherapeutics is not included in the S&P 500 index

Is Calidi Biotherapeutics in the NASDAQ 100?

No, Calidi Biotherapeutics is not included in the NASDAQ 100 index

Is Calidi Biotherapeutics in the Dow Jones?

No, Calidi Biotherapeutics is not included in the Dow Jones index

When does Calidi Biotherapeutics report earnings?

The next expected earnings date for Calidi Biotherapeutics is 30 August 2024